Non-Hematologic Malignancy — Trials

Non-Hematologic Malignancy — Trials · CancerIndex

Clinical trials

Registered studies

10 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 0
Recruiting: 0
Ph III recruiting: 0
Growth YoY: —
Industry share: —
Top sponsor: —
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (3)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT01849744	Phase I Dose Escalation Study of VS-4718 in Subjects With Metastatic Non-Hematologic Malignancies	terminated	Phase 1	48	Verastem, Inc.INDUSTRY	1	Jul 28, 2017	clinicaltrials
NCT01991938	Phase I Dose Escalation Study of VS-5584 in Subjects With Advanced Non-Hematologic Malignancies or Lymphoma	terminated	Phase 1	75	Verastem, Inc.INDUSTRY	2	Jan 27, 2017	clinicaltrials